Filing Details
- Accession Number:
- 0001415889-24-010205
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 20:32:28
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 20:32:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1920061 | R. Alex Thurman | C/O Glaukos Corporation One Glaukos Way Aliso Viejo CA 92656 | Svp & Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-01 | 1,001 | $93.10 | 55,390 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-04-02 | 44 | $88.76 | 55,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 170 | $89.71 | 55,176 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 178 | $90.76 | 54,998 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 81 | $91.74 | 54,917 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 1 | $92.74 | 54,916 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on April 1, 2020 and April 1, 2021.
- Includes 22,898 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2023.
- This transaction was executed in multiple trades at prices ranging from $88.30 to $89.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $89.32 to $90.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $90.34 to $91.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $91.34 to $92.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
